B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13
B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13
B of A Securities以中性评级启动对Inovio制药的覆盖,宣布目标价为13美元
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。